Apolipoproteins and Suicide: a Potential Psychiatry Biomarker

María Fernanda Serna-Rodríguez; Miguel Zambrano-Lucio; Jorge Luis Trejo-Luevanos; Ivan Alberto Marino-Martínez; Ana María Rivas-Estilla; José Alfonso Ontiveros-Sánchez de la Barquera; Antonio Alí Perez-Maya

doi:10.20944/preprints202208.0174.v1

A peer-reviewed article of this Preprint also exists.

Serna-Rodríguez, M.F.; Zambrano-Lucio, M.; Trejo-Luevanos, J.L.; Marino-Martínez, I.A.; Rivas-Estilla, A.M.; Ontiveros-Sánchez de la Barquera, J.A.; Pérez-Maya, A.A. Apolipoproteins and Suicide: A Potential Psychiatric Biomarker. Archives of Suicide Research 2022, 1–19, doi:10.1080/13811118.2022.2111533. Serna-Rodríguez, M.F.; Zambrano-Lucio, M.; Trejo-Luevanos, J.L.; Marino-Martínez, I.A.; Rivas-Estilla, A.M.; Ontiveros-Sánchez de la Barquera, J.A.; Pérez-Maya, A.A. Apolipoproteins and Suicide: A Potential Psychiatric Biomarker. Archives of Suicide Research 2022, 1–19, doi:10.1080/13811118.2022.2111533.

Abstract

Every year around 800 000 people commit suicide, this represents one death every 40 seconds. In the search for possible biological biomarkers associated with suicide and/or psychiatric disorders, serum cholesterol levels have been extensively explored. Several studies have indicated that cholesterol and associated proteins, especially apolipoproteins (Apos), may play an important role in the diagnosis, prognosis, and susceptibility of suicide. Here, we describe the current knowledge and findings in the relationship between apolipoproteins and suicide.

Keywords

Subject

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Apolipoproteins and Suicide: a Potential Psychiatry Biomarker

Abstract

Keywords

Subject

Comments (0)